The European Medicines Agency (EMA) said on Thursday it had approved Pfizer's anti-Covid pill, which becomes the first antiviral medicine taken by mouth authorized in the European Union.
Read alsoCovid-19: why Pfizer's Paxlovid pill will not benefit everyone at risk
The EMA “
has recommended authorizing Paxlovid for the treatment of Covid-19 in adults who do not require supplemental oxygen and who are at increased risk of the disease becoming serious
,” the European regulator said in a statement. communicated.